Generex Biotechnology Corp. of Worcester, a developer of drug delivery technology, said it has entered into an agreement with Canadian medical marijuana development firm CannScience Innovations Inc. to license its drug delivery system for delivery of medical marijuana products.
According to a statement, CannScience is developing a product pipeline of proprietary drug, device and delivery technologies. On Nov. 18, CannScience entered into a non-binding letter of intent to lease Generex’s proprietary RapidMist drug delivery technologies to be used in oral delivery of its medical marijuana products.
CannScience products will be dispensed through Canadian firm MedCannAccess now, which, according to the same statement, has acquired a minority equity stake in CannScience.
